Back to mobile site

MKM Partners Slighly Increases Amarin (AMRN) Vascepa Estimates Post Q1

May 10, 2013 11:28 AM EDT Send to a Friend
MKM Partners reiterated its Buy rating and $12 price target on Amarin Corporation (NASDAQ: AMRN) and slightly increased Vacepa estimates ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login